iRadimed Corporation (IRMD) financial statements (2021 and earlier)

Company profile

Business Address 1025 WILLA SPRINGS DR.
WINTER SPRINGS, FL 32708
State of Incorp.
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments52463426262717
Cash and cash equivalents5043281818199
Short-term investments2368888
Receivables5744442
Inventory, net of allowances, customer advances and progress billings4444422
Inventory4444422
Prepaid expense2110000
Deferred tax assets  000
Other undisclosed current assets1011000
Total current assets:64594535343422
Noncurrent Assets
Operating lease, right-of-use asset3 
Property, plant and equipment2222111
Intangible assets, net (including goodwill)1111100
Intangible assets, net (excluding goodwill)1111100
Deferred income tax assets1 
Other noncurrent assets0000000
Other undisclosed noncurrent assets 511000
Total noncurrent assets:7844311
TOTAL ASSETS:71674839373523
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3432322
Accounts payable1111111
Accrued liabilities0000000
Employee-related liabilities2222111
Taxes payable0100000
Deferred revenue2 
Deferred revenue and credits2110
Contract with customer, liability22
Other liabilities00000  
Other undisclosed current liabilities00     
Total current liabilities:5654432
Noncurrent Liabilities
Long-term debt and lease obligation2      
Operating lease, liability2 
Liabilities, other than long-term debt2322200
Deferred revenue and credits2200
Deferred revenue2 
Contract with customer, liability32
Other undisclosed noncurrent liabilities 3     
Total noncurrent liabilities:5522200
Total liabilities:101166532
Stockholders' equity
Stockholders' equity attributable to parent61564233323221
Common stock0000000
Additional paid in capital24191513121916
Accumulated other comprehensive income (loss)00(0)(0)(0)(0)(0)
Retained earnings3836272020135
Total stockholders' equity:61564233323221
TOTAL LIABILITIES AND EQUITY:71674839373523

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues32393023323216
Cost of revenue(8)(9)(7)(6)(6)(6)(3)
Gross profit:24302318262612
Operating expenses(24)(21)(17)(16)(15)(14)(9)
Operating income (loss):(1)96111123
Nonoperating income (expense)000000(0)
Investment income, nonoperating000000 
Foreign currency transaction gain (loss), before tax(0)(0)(0)(0)(0)(0)0
Income (loss) from continuing operations before income taxes:(1)96111123
Income tax expense (benefit)210(1)(4)(4)(1)
Net income available to common stockholders, diluted:11060782

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income:11060782
Other comprehensive income (loss)000(0)0(0)(0)
Comprehensive income, net of tax, attributable to parent:11060772

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: